TherapeuticsMD Inc (NYSEMKT:TXMD), Director Cooper C. Collins bought 20,000 shares of TherapeuticsMD stock in a transaction dated Thursday, June 5th. The shares were purchased at an average price of $3.84 per share, for a total transaction of $76,800.00. Following the completion of the purchase, the director now directly owns 20,000 shares in the company, valued at approximately $76,800. TherapeuticsMD Inc (NYSEMKT:TXMD), weekly performance is 19.53%. On last trading day company shares ended up $4.59. Analysts mean target price for the company is $10.00. TherapeuticsMD Inc (NYSEMKT:TXMD), distance from 50-day simple moving average (SMA50) is 4.75%.
OraSure Technologies, Inc. (NASDAQ:OSUR), has scheduled an investor conference call and simultaneous webcast for 8:30 a.m. ET (5:30 a.m. PT) on Wednesday, June 11, 2014 to provide an update on certain developments related to its OraQuick® HCV business. OraSure Technologies, Inc. (NASDAQ:OSUR), advanced 5.86% in last trading session and ended the day on $7.23. OSUR, Gross Margin is 59.70% and its return on assets is -3.70%. OraSure Technologies, Inc. (NASDAQ:OSUR), quarterly performance is -10.96%.
Shares of Allied Nevada Gold Corp. (NYSEMKT:ANV), saw a significant increase in short interest in the month of May. As of May 30th, there was short interest totalling 34,337,941 shares, an increase of 0.9% from the May 15th total of 34,018,113 shares, Stock Ratings News reports. Approximately 35.8% of the company’s shares are short sold. Based on an average daily trading volume, of 2,457,740 shares, the days-to-cover ratio is presently 14.0 days. Allied Nevada Gold Corp. (NYSEMKT:ANV), shares moved up 8.75% in last trading session and was closed at $3.23, while trading in range of $3.00 – 3.25. Allied Nevada Gold Corp. (NYSEMKT:ANV), year to date (YTD) performance is -9.01%.
Silver Standard Resources Inc. (USA) (NASDAQ:SSRI), had its price objective lowered by RBC Capital from $12.00 to $11.00 in a research report released on Thursday morning. Silver Standard Resources Inc. (USA) (NASDAQ:SSRI), ended the last trading day at $7.20. Company weekly volatility is calculated as 4.20% and price to cash ratio as 1.06. Silver Standard Resources Inc. (USA) (NASDAQ:SSRI), showed a positive weekly performance of 12.15%.
Analysts at FBR Capital Markets dropped their price target on shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP), from $17.00 to $16.00 in a research report issued to clients and investors on Tuesday. The firm currently has an “outperform” rating on the stock. FBR Capital Markets’ target price would indicate a potential upside of 88.46% from the company’s current price. Raptor Pharmaceutical Corp. (NASDAQ:RPTP), weekly performance is 33.12%. On last trading day company shares ended up $10.53. Analysts mean target price for the company is $21.00. Raptor Pharmaceutical Corp. (NASDAQ:RPTP), distance from 50-day simple moving average (SMA50) is 24.69%.